Molecular Profile Detail

Case insensitive filtering will display rows if any text in any cell matches the filter term
Use simple literal full or partial string matches
Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
Click on any column header arrows to sort by that column
Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Clinical Trial	Phase	Therapies	Title	Recruitment Status	Covered Countries	Other Countries
NCT05751044	Phase Ib/II	Cyclophosphamide + Cytarabine + Dasatinib + Dexamethasone + Venetoclax	HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (HEM-iSMART B)	Recruiting	SWE \| NOR \| NLD \| ITA \| ISR \| IRL \| GBR \| FRA \| FIN \| ESP \| DNK \| DEU \| BEL \| AUT	0
NCT06124157	Phase III	Blinatumomab + Dasatinib Imatinib Methotrexate Pegaspargase Thioguanine Cytarabine Mercaptopurine Leucovorin Dasatinib Blinatumomab + Imatinib Prednisone Daunorubicin Doxorubicin Prednisolone Cyclophosphamide	A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)	Recruiting	USA \| CAN \| AUS	1

Profile Name	ABL1 fusion
Gene Variant Detail	ABL1 fusion (unknown)
Relevant Treatment Approaches